S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q2 2021

Avoro Capital Advisors

Periodo: Q2 2021 Β· Depositato: 2021-08-16
Vedi su SEC EDGAR β†—
AUM
$5.75B
Valore totale del portafoglio
Posizioni
46
Titoli dichiarati
Prima Posizione
HZNP
14.7% $842.8M
Var. Trimestrali
+6 / -7
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-08-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
HZNPHORIZON THERAPEUTICS PLC$842.8M14.66%β€”β€”
14.7%
MRTXMIRATI THERAPEUTICS INC$807.6M14.05%β€”β€”
14.1%
UTHRUNITED THERAPEUTICS CORP$538.2M9.36%$179.41$555.91+209.8%
9.4%
XLRNACCELERON PHARMA INC$376.5M6.55%β€”β€”
6.5%
ARGXARGENX SE$285.0M4.96%$301.07$939.68+212.1%
5.0%
ARNAARENA PHARMACEUTICALS INC$277.9M4.83%β€”β€”
4.8%
ASNDASCENDIS PHARMA$249.9M4.35%$131.55$274.50+108.7%
4.3%
IOVAIOVANCE BIOTHERAPEUTICS INC$236.8M4.12%$26.02$4.31-83.4%
4.1%
SRPTSAREPTA THERAPEUTICS INC$186.6M3.25%$77.74$19.28-75.2%
3.3%
ALNYALNYLAM PHARMACEUTICALS INC$169.5M2.95%$169.52$312.78+84.5%
3.0%
VRTXVERTEX PHARMACEUTICALS INC$159.3M2.77%$201.63$528.04+161.9%
2.8%
MDGLMADRIGAL PHARMACEUTICALS INC$138.8M2.41%$97.41$528.10+442.1%
2.4%
BMRNBIOMARIN PHARMACEUTICAL INC$137.7M2.39%$83.44$58.99-29.3%
2.4%
FOLDAMICUS THERAPEUTICS INC$120.0M2.09%β€”β€”
2.1%
CNSTCONSTELLATION PHARMACEUTICALS INC$108.5M1.89%β€”β€”
1.9%
MRSNMERSANA THERAPEUTICS INC$92.3M1.61%β€”β€”
1.6%
KURAKURA ONCOLOGY INC$86.3M1.50%$20.85$11.10-46.8%
1.5%
XENEXENON PHARMACEUTICALS INC$68.0M1.18%$18.62$60.96+227.4%
1.2%
APLSAPELLIS PHARMACEUTICALS INC$63.5M1.11%$63.20β€”
1.1%
PMVPPMV PHARMACEUTICALS INC$62.3M1.08%$34.16$1.22-96.4%
1.1%
GLUEMONTE ROSA THERAPEUTICS INC$62.1M1.08%$22.70$24.21+6.7%
1.1%
ACADACADIA PHARMACEUTICALS INC$59.5M1.04%$24.39$25.97+6.5%
1.0%
MRNSMARINUS PHARMACEUTICALS INC$58.0M1.01%β€”β€”
1.0%
TRILLIUM THERAPEUTICS INC$55.3M0.96%β€”β€”
1.0%
SNDXSYNDAX PHARMACEUTICALS INC$51.5M0.90%$17.17$21.82+27.1%
0.9%
MNKDMANNKIND CORP$47.0M0.82%$5.45$4.52-17.1%
0.8%
CBAYCYMABAY THERAPEUTICS INC$44.9M0.78%β€”β€”
0.8%
ISEEIVERIC BIO INC$40.5M0.71%β€”β€”
0.7%
DCPHDECIPHERA PHARMACEUTICALS INC$39.1M0.68%β€”β€”
0.7%
RLMDRELMADA THERAPEUTICS INC$29.9M0.52%$32.01$6.28-80.4%
0.5%

AttivitΓ  Trimestre su Trimestre

Q2 2021 vs. Q1 2021

Nuove Posizioni (6)

TickerEmittenteNozionaleDal Deposito
ASNDASCENDIS PHARMA$249.9M+108.7%
ALNYCALLALNYLAM PHARMACEUTICALS INC$169.5M+84.5%
GLUEMONTE ROSA THERAPEUTICS INC$62.1M+6.7%
CNTACENTESSA PHARMACEUTICALS PLC$11.1M
ARPOAERPIO PHARMACEUTICALS INC$7.6M
ALNYCALLALNYLAM PHARMACEUTICALS INC$1.4M+84.5%

Posizioni Chiuse (7)

TickerEmittenteNozionale
ASCENDIS PHARMA$244.9M
TVTXTRAVERE THERAPEUTICS INC$31.2M
RLAYRELAY THERAPEUTICS INC$17.3M
BDTXBLACK DIAMOND THERAPEUTICS INC$10.7M
RACATHERAPEUTICS ACQUISITION CORP$10.5M
JNCEJOUNCE THERAPEUTICS INC$5.7M
LKFTGALAPAGOS NV$0.2M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SNDXSYNDAX PHARMACEUTICALS INC$-4.4M+20.0%+27.1%
DCPHDECIPHERA PHARMACEUTICALS INC$-0.9M+19.6%
MNKDMANNKIND CORP$17.6M+15.1%-17.1%
IOVAIOVANCE BIOTHERAPEUTICS INC$-16.5M+13.8%-83.4%
SRPTSAREPTA THERAPEUTICS INC$26.3M+11.6%-75.2%
CNSTCONSTELLATION PHARMACEUTICALS INC$39.5M+8.8%
MRTXMIRATI THERAPEUTICS INC$6.8M+7.0%
KURAKURA ONCOLOGY INC$-26.8M+3.5%-46.8%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
APLSCALLAPELLIS PHARMACEUTICALS INC$-39.5M-76.0%
VRTXVERTEX PHARMACEUTICALS INC$-141.6M-43.6%+161.9%
ADAPYADAPTIMMUNE THERAPEUTICS PLC$-10.2M-43.0%
RLMDRELMADA THERAPEUTICS INC$-23.8M-38.7%-80.4%
PMVPPMV PHARMACEUTICALS INC$-15.3M-22.7%-96.4%
ADVMADVERUM BIOTECHNOLOGIES INC$-54.6M-13.1%
ISEEIVERIC BIO INC$-4.3M-11.4%
ACADACADIA PHARMACEUTICALS INC$-5.0M-2.3%+6.5%
← Torna agli Hedge Fund